NewAmsterdam’s obicetrapib holds potential to become first CETP inhibitor to advance to clinical practice: GlobalData Read more
Pfizer’s gene therapy for Haemophilia A receives positive topline results from Phase 3 Study Read more
Synergistic safety profile could increase sublingual apomorphine competitiveness: GlobalData Read more
VNS and cenobamate combo therapy success paves way for cenobamate monotherapy, says GlobalData Read more